client Servier

Pancreatic cancer and new therapeutic scenarios

our expertise Organization of a media tutorial on ā€œPancreatic cancer in advanced stages: clinical needs and new therapeutic scenariosā€, featuring top oncology experts to support the Italian launch of pegylated liposomal irinotecan Nal-IRI—the first approved second-line treatment for pancreatic cancer. Managed…